Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer.
Name:
PIIS2352396418301476.pdf
Size:
1007.Kb
Format:
PDF
Description:
Full text, Open Access article
Authors
Yang, LingjianRoberts, Darren L
Takhar, M
Erho, N
Bibby, B
Thiruthaneeswaran, N
Bhandari, V
Cheng, W
Haider, S
McCorry, A
McArt, D
Jain, S
Alshalalfa, M
Ross, A
Schaffer, E
Den, R
Jeffrey Karnes, R
Klein, Eric
Hoskin, P
Freedland, S
Lamb, A
Neal, D
Buffa, F
Bristow, R
Boutros, P
Davicioni, E
Choudhury, Ananya
West, Catharine M L
Affiliation
Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester M20 4BXIssue Date
2018-05
Metadata
Show full item recordAbstract
Hypoxia is associated with a poor prognosis in prostate cancer. This work aimed to derive and validate a hypoxia-related mRNA signature for localized prostate cancer.Citation
Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer. 2018, 31: 182-189 EBioMedicineJournal
EBioMedicineDOI
10.1016/j.ebiom.2018.04.019PubMed ID
29729848Type
ArticleLanguage
enISSN
2352-3964ae974a485f413a2113503eed53cd6c53
10.1016/j.ebiom.2018.04.019